Neylan JF et al. |
Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine. |
1998 |
Am. J. Kidney Dis. |
pmid:9820446
|
Igarashi K et al. |
A novel indication of the activities of small molecule inhibitors of protein-protein interactions: application of the yeast two-hybrid system. |
1998 |
J. Antibiot. |
pmid:9820241
|
Campo JV et al. |
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent. |
1998 |
Arch. Gen. Psychiatry |
pmid:9819077
|
Perego C et al. |
Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506. |
1998 |
Int. J. Immunopharmacol. |
pmid:9818792
|
Ader JL and Rostaing L |
Cyclosporin nephrotoxicity: pathophysiology and comparison with FK-506. |
1998 |
Curr. Opin. Nephrol. Hypertens. |
pmid:9818201
|
Wells WA |
Coming full circle. Vertex Pharmaceuticals, Inc. |
1998 |
Chem. Biol. |
pmid:9818152
|
Shapiro R et al. |
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. |
1998 |
J. Urol. |
pmid:9817305
|
Bachinger A et al. |
[Immunosuppression with tacrolimus (FK 506) and cyclosporin A for preventing graft rejection after liver transplantation. Retrospective evaluation of medical costs based on the FG-O157 Study in 224 patients (Germany)]. |
1998 |
Chirurg |
pmid:9816454
|
Walder B et al. |
Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation. |
1998 |
J. Heart Lung Transplant. |
pmid:9811409
|
Marton MJ et al. |
Drug target validation and identification of secondary drug target effects using DNA microarrays. |
1998 |
Nat. Med. |
pmid:9809554
|
Krähenbühl S et al. |
Serious interaction between mibefradil and tacrolimus. |
1998 |
Transplantation |
pmid:9808502
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Hultsch T et al. |
Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. |
1998 |
Arch. Dermatol. Res. |
pmid:9808344
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Faure JD et al. |
An Arabidopsis immunophilin, AtFKBP12, binds to AtFIP37 (FKBP interacting protein) in an interaction that is disrupted by FK506. |
1998 |
Plant J. |
pmid:9807817
|
Boguniewicz M et al. |
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. |
1998 |
J. Allergy Clin. Immunol. |
pmid:9802373
|
Bieber T |
Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. |
1998 |
J. Allergy Clin. Immunol. |
pmid:9802361
|
Reis A et al. |
A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation. |
1998 |
Graefes Arch. Clin. Exp. Ophthalmol. |
pmid:9801895
|
Conti F et al. |
Low level of interleukin 10 synthesis during liver allograft rejection. |
1998 |
Lab. Invest. |
pmid:9800954
|